Tissue-engineered fibrin-based heart valve with a tubular leaflet design

Tissue Engineering - Part C: Methods

Volumn 20, Issue 4, 2014, Pages 265-275

  Weber, Miriam ^a   Heta, Eriona ^a   Moreira, Ricardo ^a   Gesche, Valentine N ^b   Schermer, Thomas ^a   Frese, Julia ^a   Jockenhoevel, Stefan ^a,b   Mela, Petra ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; DESIGN; MECHANICAL PROPERTIES; TISSUE ENGINEERING; TUBES (COMPONENTS);

CIRCUMFERENTIAL LINE; CONVENTIONAL DESIGN; HAEMOCOMPATIBILITY; HEART VALVE TISSUE ENGINEERINGS; IMPLANTATION TECHNIQUE; TISSUE FORMATION; TISSUE-ENGINEERED HEART; TUBULAR CONSTRUCTS;

TISSUE;

FIBRIN;

ANIMAL TISSUE; ARTICLE; EMBEDDING; GEOMETRY; HEART VALVE; HEART VALVE PROSTHESIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; NONHUMAN; PRIORITY JOURNAL; SHEEP; TISSUE ENGINEERING; TUBULAR LEAFLET DESIGNED HEART VALVE; UMBILICAL ARTERY;

ANIMALS; BIOREACTORS; FIBRIN; FLUORESCENCE; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; IMMUNOHISTOCHEMISTRY; PROSTHESIS DESIGN; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84897430714     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2013.0258     Document Type: Article

References (58)

1. Otto, C.M., Lind, B.K., Kitzman, D.W., Gersh, B.J., and Siscovick, D.S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341, 142, 1999.
2. Dujardin, K.S., Enriquez-Sarano, M., Schaff, H.V., Bailey, K.R., Seward, J.B., and Tajik, A.J. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term followup study. Circulation 99, 1851, 1999.
3. Nkomo, V.T., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., and Enriquez-Sarano, M. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005, 2006.
4. D'arcy, J.L., Prendergast, B.D., Chambers, J.B., Ray, S.G., and Bridgewater, B. Valvular heart disease: the next cardiac epidemic. Heart 97, 91, 2011.
5. Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M.J., Baron-Esquivias, G., Baumgartner, H., Borger, M.A., Carrel, T.P., De Bonis, M., Evangelista, A., Falk, V., Iung, B., Lancellotti, P., Pierard, L., Price, S., Schafers, H.J., Schuler, G., Stepinska, J., Swedberg, K., Takkenberg, J., Von Oppell, U.O., Windecker, S., Zamorano, J.L., Zembala, M., Bax, J.J., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Knuuti, J., Kolh, P., Mcdonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., Sechtem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Von Segesser, L., Badano, L.P., Bunc, M., Claeys, M.J., Drinkovic, N., Filippatos, G., Habib, G., Kappetein, A.P., Kassab, R., Lip, G.Y., Moat, N., Nickenig, G., Otto, C.M., Pepper, J., Piazza, N., Pieper, P.G., Rosenhek, R., Shuka, N., Schwammenthal, E., Schwitter, J., Mas, P.T., Trindade, P.T., and Walther, T. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33, 2451, 2012.
6. Schoen, F.J., and Levy, R.J. Pathology of substitute heart valves: new concepts and developments. J Card Surg 9, 222, 1994.
7. Eitz, T., Fritzsche, D., Kleikamp, G., Zittermann, A., Horstkotte, D., and Korfer, R. Reoperation of the aortic valve in octogenarians. Ann Thorac Surg 82, 1385, 2006.
8. Hanania, G., Michel, P.L., Montely, J.M., Warembourg, H., Nardi, O., Leguerrier, A., Agnino, A., Despins, P., Legault, B., Petit, H., and Bouraindeloup, M. [The long term (15 years) evolution after valvular replacement with mechanical prosthesis or bioprosthesis between the age of 60 and 70 years]. Arch Mal Coeur Vaiss 97, 7, 2004.
9. Mol, A., Smits, A.I., Bouten, C.V., and Baaijens, F.P. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 6, 259, 2009.
10. Schoen, F.J. Heart valve tissue engineering: quo vadis? Curr Opin Biotechnol 22, 698, 2011.
11. Butcher, J.T., Mahler, G.J., and Hockaday, L.A. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev 63, 242, 2011.
12. Jockenhoevel, S., Chalabi, K., Sachweh, J.S., Groesdonk, H.V., Demircan, L., Grossmann, M., Zund, G., and Messmer, B.J. Tissue engineering: complete autologous valve conduit-a new moulding technique. Thorac Cardiovasc Surg 49, 287, 2001.
13. Sodian, R., Sperling, J.S., Martin, D.P., Egozy, A., Stock, U., Mayer, J.E., Jr., and Vacanti, J.P. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng 6, 183, 2000.
14. Cox, M.A., Kortsmit, J., Driessen, N., Bouten, C.V., and Baaijens, F.P. Tissue-engineered heart valves develop nativelike collagen fiber architecture. Tissue Eng Part A 16, 1527, 2010.
15. Neidert, M.R., and Tranquillo, R.T. Tissue-engineered valves with commissural alignment. Tissue Eng 12, 891, 2006.
16. Shinoka, T., Breuer, C.K., Tanel, R.E., Zund, G., Miura, T., Ma, P.X., Langer, R., Vacanti, J.P., and Mayer, J.E., Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 60, S513, 1995.
17. Klopsch, C., Gabel, R., Kaminski, A., Mark, P., Wang, W., Toelk, A., Delyagina, E., Kleiner, G., Koch, L., Chichkov, B., Mela, P., Jockenhoevel, S., Ma, N., and Steinhoff, G. Sprayand laser-assisted biomaterial processing for fast and efficient autologous cell-plus-matrix tissue engineering. J Tissue Eng Regen Med 2012. [Epub ahead of print]; DOI: 10.1002/term.1657.
18. Courtney, T., Sacks, M.S., Stankus, J., Guan, J., and Wagner, W.R. Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials 27, 3631, 2006.
19. Hong, H., Dong, N., Shi, J., Chen, S., Guo, C., Hu, P., and Qi, H. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study. Artif Organs 33, 554, 2009.
20. Sauren, A.A., Van Hout, M.C., Van Steenhoven, A.A., Veldpaus, F.E., and Janssen, J.D. The mechanical properties of porcine aortic valve tissues. J Biomech 16, 327, 1983.
21. Sacks, M.S., and Yoganathan, A.P. Heart valve function: a biomechanical perspective. Philos Trans R Soc Lond B Biol Sci 362, 1369, 2007.
22. Mueller, X.M., and Von Segesser, L.K. A new equine pericardial stentless valve. J Thorac Cardiovasc Surg 125, 1405, 2003.
23. Goetz, W.A., Lim, H.S., Lansac, E., Weber, P.A., and Duran, C.M. A temporarily stented, autologous pericardial aortic valve prosthesis. J Heart Valve Dis 11, 696, 2002.
24. Linneweber, J., Heinbokel, T., Christ, T., Claus, B., Kossagk, C., and Konertz, W. Clinical experience with the ATS 3F stentless aortic bioprosthesis: five years' follow up. J Heart Valve Dis 19, 772, 2010.
25. Cox, J.L., Ad, N., Myers, K., Gharib, M., and Quijano, R.C. Tubular heart valves: a new tissue prosthesis design-preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg 130, 520, 2005.
26. Goetz, W.A., Tan, T.E., Lim, K.H., Salgues Sle, H., Grousson, N., Xiong, F., Chua, Y.L., and Yeo, J.H. Truly stentless molded autologous pericardial aortic valve prosthesis with single point attached commissures in a sheep model. Eur J Cardiothorac Surg 33, 548, 2008.
27. Schoen, F.J., and Levy, R.J. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79, 1072, 2005.
28. Myers, J.L. Invited letter concerning: calcification after endto-end arterial anastomoses. J Thorac Cardiovasc Surg 99, 380, 1990.
29. Flanagan, T.C., Sachweh, J.S., Frese, J., Schnoring, H., Gronloh, N., Koch, S., Tolba, R.H., Schmitz-Rode, T., and Jockenhoevel, S. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15, 2965, 2009.
30. Robinson, P.S., Johnson, S.L., Evans, M.C., Barocas, V.H., and Tranquillo, R.T. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng Part A 14, 83, 2008.
31. Mol, A., Rutten, M.C., Driessen, N.J., Bouten, C.V., Zund, G., Baaijens, F.P., and Hoerstrup, S.P. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 114, I152, 2006.
32. Cholewinski, E., Dietrich, M., Flanagan, T.C., Schmitz-Rode, T., and Jockenhoevel, S. Tranexamic acid-an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng Part A 15, 3645, 2009.
33. Flanagan, T.C., Cornelissen, C., Koch, S., Tschoeke, B., Sachweh, J.S., Schmitz-Rode, T., and Jockenhoevel, S. The in vitro development of autologous fibrin-based tissueengineered heart valves through optimised dynamic conditioning. Biomaterials 28, 3388, 2007.
34. Reul, H., Vahlbruch, A., Giersiepen, M., Schmitz-Rode, T., Hirtz, V., and Effert, S. The geometry of the aortic root in health, at valve disease and after valve replacement. J Biomech 23, 181, 1990.
35. Goetz, W.A., Lim, K.H., Ibled, R., Grousson, N., Satgues, S.L.H., and Yeo, J.H. Forces at single point attached commissures (SPAC) in pericardial aortic valve prosthesis. Eur J Cardio-Thorac 29, 150, 2006.
36. Doss, M., Martens, S., Wood, J.P., Miskovic, A., Christodoulou, T., Wimmer-Greinecker, G., and Moritz, A. Aortic leaflet replacement with the new 3F stentless aortic bioprosthesis. Ann Thorac Surg 79, 682, 2005.
37. Risteski, P., Adami, C., Papadopoulos, N., Sirat, A.S., Moritz, A., and Doss, M. Leaflet replacement for aortic stenosis using the 3f stentless aortic bioprosthesis: midterm results. Ann Thorac Surg 93, 1134, 2012.
38. Eckstein, F.S., Tevaearai, H., Keller, D., Schmidli, J., Immer, F.F., Seiler, C., Saner, H., and Carrel, T.P. Early clinical experience with a new tubular equine pericardial stentless aortic valve. Heart Surg Forum 7, E498, 2004.
39. Masumoto, H., Watanabe, T., Sakai, Y., and Ueda, Y. [Experimental study of calcification of the xenopericardia]. Kyobu Geka 53, 468, 2000.
40. Al Halees, Z., Al Shahid, M., Al Sanei, A., Sallehuddin, A., and Duran, C. Up to 16 years follow-up of aortic valve reconstruction with pericardium: a stentless readily available cheap valve? Eur J Cardiothorac Surg 28, 200, 2005.
41. Syedain, Z., Lahti, M., Johnson, S., Robinson, P., Ruth, G., Bianco, R., and Tranquillo, R. Implantation of a tissueengineered heart valve from human fibroblasts exhibiting short term function in the sheep pulmonary artery. Cardiovasc Eng Tech 2, 101, 2011.
42. Hoffman, D., Gong, G., Liao, K., Macaluso, F., Nikolic, S.D., and Frater, R.W. Spontaneous host endothelial growth on bioprostheses. Influence of fixation. Circulation 86, II75, 1992.
43. Weinandy, S., Rongen, L., Schreiber, F., Cornelissen, C., Flanagan, T.C., Mahnken, A., Gries, T., Schmitz-Rode, T., and Jockenhoevel, S. The BioStent: novel concept for a viable stent structure. Tissue Eng Part A 18, 1818, 2012.
44. Marom, G., Haj-Ali, R., Rosenfeld, M., Schafers, H.J., and Raanani, E. Aortic root numeric model: annulus diameter prediction of effective height and coaptation in post-aortic valve repair. J Thorac Cardiovasc Surg 145, 406, 2013.
45. Kunzelman, K.S., Grande, K.J., David, T.E., Cochran, R.P., and Verrier, E.D. Aortic root and valve relationships. Impact on surgical repair. J Thorac Cardiovasc Surg 107, 162, 1994.
46. Xiong, F.L., Goetz, W.A., Chong, C.K., Chua, Y.L., Pfeifer, S., Wintermantel, E., and Yeo, J.H. Finite element investigation of stentless pericardial aortic valves: relevance of leaflet geometry. Ann Biomed Eng 38, 1908, 2010.
47. Spray, T.L., and Roberts, W.C. Structural changes in porcine xenografts used as substitute cardiac valves. Gross and histologic observations in 51 glutaraldehyde-preserved Hancock valves in 41 patients. Am J Cardiol 40, 319, 1977.
48. Christie, G.W. Computer modelling of bioprosthetic heart valves. Eur J Cardiothorac Surg 6 Suppl 1, S95, 1992.
49. Thubrikar, M., Bosher, L.P., and Nolan, S.P. The mechanism of opening of the aortic valve. J Thorac Cardiovasc Surg 77, 863, 1979.
50. Robicsek, F., Thubrikar, M.J., and Fokin, A.A. Cause of degenerative disease of the trileaflet aortic valve: review of subject and presentation of a new theory. Ann Thorac Surg 73, 1346, 2002.
51. Pang, D.C., Choo, S.J., Luo, H.H., Shomura, Y.U., Daniel, S., Nikolic, S., Cheung, D.T., Oury, J.H., and Duran, C.M. Significant increase of aortic root volume and commissural area occurs prior to aortic valve opening. J Heart Valve Dis 9, 9, 2000.
52. Freed, L.E., Guilak, F., Guo, X.E., Gray, M.L., Tranquillo, R., Holmes, J.W., Radisic, M., Sefton, M.V., Kaplan, D., and Vunjak-Novakovic, G. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 12, 3285, 2006.
53. Stock, U.A., and Vacanti, J.P. Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng 7, 1, 2001.
54. Syedain, Z.H., and Tranquillo, R.T. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30, 4078, 2009.
55. Syedain, Z.H., Weinberg, J.S., and Tranquillo, R.T. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci USA 105, 6537, 2008.
56. Rubbens, M.P., Mol, A., Boerboom, R.A., Bank, R.A., Baaijens, F.P., and Bouten, C.V. Intermittent straining accelerates the development of tissue properties in engineered heart valve tissue. Tissue Eng Part A 15, 999, 2009.
57. Gandaglia, A., Bagno, A., Naso, F., Spina, M., and Gerosa, G. Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Eur J Cardiothorac Surg 39, 523, 2011.
58. Koch, S., Flanagan, T.C., Sachweh, J.S., Tanios, F., Schnoering, H., Deichmann, T., Ella, V., Kellomaki, M., Gronloh, N., Gries, T., Tolba, R., Schmitz-Rode, T., and Jockenhoevel, S. Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation. Biomaterials 31, 4731, 2010.